<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39399920</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 infection and the risk of depressive symptoms: a retrospective longitudinal study from the population-based CONSTANCES cohort.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291724002435</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Should COVID-19 have a direct impact on the risk of depression, it would suggest specific pathways for prevention and treatment. In this retrospective population-based study, we aimed to examine the association of prior SARS-CoV-2 infection with depressive symptoms, distinguishing self-reported <i>v</i>. biologically confirmed COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">32 007 participants from the SAPRIS survey nested in the French CONSTANCES cohort were included. COVID-19 was measured as followed: <i>ad hoc</i> serologic testing, self-reported PCR or serology positive test results, and self-reported COVID-19. Depressive symptoms were measured with the Center of Epidemiologic Studies-Depression Scale (CES-D). Outcomes were depressive symptoms (total CES-D score, its four dimensions, and clinically significant depressive symptoms) and exposure was prior COVID-19 (no COVID-19/self-reported unconfirmed COVID-19/biologically confirmed COVID-19).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In comparison to participants without COVID-19, participants with self-reported unconfirmed COVID-19 and biologically confirmed COVID-19 had higher CES-D scores (<i>&#x3b2;</i> for one interquartile range increase [95% CI]: 0.15 [0.08-0.22] and 0.09 [0.05-0.13], respectively) and somatic complaints dimension scores (0.15 [0.09-0.21] and 0.10 [0.07-0.13]). Only those with self-reported but unconfirmed COVID-19 had higher depressed affect dimension scores (0.08 [0.01-0.14]). Accounting for <i>ad hoc</i> serologic testing only, the CES-D score and the somatic complaints dimension were only associated with the combination of self-reported COVID-19 and negative serology test results.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The association between COVID-19 and depressive symptoms was merely driven by somatic symptoms of depression and did not follow a gradient consistent with the hypothesis of a direct impact of SARS-CoV-2 infection on the risk of depression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pignon</LastName><ForeName>Baptiste</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0526-3136</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiernik</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranque</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, AP-HP, H&#xf4;pital europ&#xe9;en Georges-Pompidou, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robineau</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Institut Pierre-Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EA2694, Univ Lille, Centre Hospitalier de Tourcoing, Tourcoing, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrat</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Institut Pierre-Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de sant&#xe9; publique, AP-HP, H&#xf4;pital Saint-Antoine, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, UVSQ, INSERM, CESP U1018, Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Computer Science, Applications 'G. Parenti,' University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touvier</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Centre of Research in Epidemiology and Statistics (CRESS) - Universit&#xe9; Paris Cit&#xe9; (CRESS), Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouraud</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouazana Vedrines</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitron</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, VIFASOM (Vigilance Fatigue Sommeil et Sant&#xe9; Publique), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre du Sommeil et de la Vigilance-Pathologie professionnelle, APHP, H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoertel</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM U1266, Institut de Psychiatrie et Neuroscience de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie et Addictologie, AP-HP, H&#xf4;pital Corentin-Celton, DMU Psychiatrie et Addictologie, Issy-les-Moulineaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kab</LastName><ForeName>Sofiane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebeka</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM U1266, Institut de Psychiatrie et Neuroscience de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zins</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemogne</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">depressive symptoms</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399920</ArticleId><ArticleId IdType="doi">10.1017/S0033291724002435</ArticleId><ArticleId IdType="pii">S0033291724002435</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>